Status:
TERMINATED
Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy
Lead Sponsor:
University of Oslo School of Pharmacy
Conditions:
Acute Renal Failure
Cytomegalovirus Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
In order to optimize anti-cytomegalovirus (CMV) treatment with ganciclovir (GCV), in patients with multi organ failure treated with continuous renal replacement therapy (RRT), more information about g...
Eligibility Criteria
Inclusion
- Patients in need of continuous RRT and GCV treatment
- 18 years of age or older.
Exclusion
- Concomitant treatment with acyclovir or valacyclovir.
- Patient does not give informed consent.
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2007
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00264368
Start Date
December 1 2005
End Date
June 1 2007
Last Update
June 28 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rikshospitalet, Section of Nephrology
Oslo, Norway, 0027